martes, 7 de enero de 2020

Biotech 2020 preview: takeover targets, notable drug launches, and more

Biotech 2020 preview: takeover targets, notable drug launches, and more

Cancer Briefing

STAT Plus: Biotech 2020 preview: Takeover targets, notable drug launches, and genome editing readouts

By ADAM FEUERSTEIN


Here's what to watch as the new year gets underway — some trends and burning questions about M&A, genome editing, and cell therapy.

No hay comentarios: